HLTH — Stock Film
STOCK FILMSCENE 1/7HLTH · $25.20
Stock Expert AI presents
HLTH
Tema Healthcare AI ETF
~2 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Tema Healthcare AI ETF. A quick introduction.

On the stock market since 2026, it operates in the world of money and finance. Now — the numbers.

on the stock market since 2026
$0 market value
THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Heavy investment in the future10/10
WEAK SPOTS
The stock has lost its spark0/10
Growth has stalled2/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

THE BRIGHT SIDE

Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.

1
THE RISKS · 1/2
The stock has lost its spark

The price action doesn’t yet back an upward turn. Council score: 0/10.

2
THE RISKS · 2/2
Growth has stalled

The sales tempo runs behind the sector. Council score: 2/10.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, HLTH sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: HLTH is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film